Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies

Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 4

Abstract

The advancement of therapeutic monoclonal antibodies during various stages of the drug development process can be effectively streamlined when appropriate translational strategies are applied. Design of successful translational strategies for development of monoclonal antibodies should allow for understanding of the dose– and concentration–response relationships with respect to both beneficial and toxic effects from early phases of drug development. Evaluation of relevant biomarkers during early stages of drug development should facilitate the successful design of safe and effective dosing strategies. Moreover, application of quantitative pharmacology is critical for translation of exposure–response relationships early on.

Authors and Affiliations

Mohammad Tabrizi, Cherryl Funelas, Hamza Suria

Keywords

Related Articles

Comparative Pharmacology and Toxicology of Pharmaceuticals in the Environment: Diphenhydramine Protection of Diazinon Toxicity in Danio rerio but Not Daphnia magna

Pharmaceuticals and other contaminants of emerging concern present unique challenges to environmental risk assessment and management. Fortunately, mammalian pharmacology and toxicology safety data are more readily availa...

Role of animal models in the study of drug-induced hypersensitivity reactions

Drug-induced hypersensitivity reactions (DHRs) are a major problem, in large part because of their unpredictable nature. If we understood the mechanisms of these reactions better, they might be predictable. Their unpredi...

Antidrug Antibody Assay Validation: Industry Survey Results

Immunogenicity of biopharmaceutical products has attracted considerable attention from the industrial, academia, and regulatory organizations. Many methods exist to detect and characterize level of antidrug antibody resp...

Polyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate

Multidrug resistance (MDR) is one of the major obstacles limiting the efficacy of cancer chemotherapy. Identification of new and effective MDR reversal agents is needed. In this study, the effects of polyoxyethylene 40 s...

Download PDF file
  • EP ID EP681408
  • DOI  10.1208/s12248-010-9220-2
  • Views 81
  • Downloads 0

How To Cite

Mohammad Tabrizi, Cherryl Funelas, Hamza Suria (2010). Application of Quantitative Pharmacology in Development of Therapeutic Monoclonal Antibodies. The AAPS Journal, 12(4), -. https://europub.co.uk./articles/-A-681408